CME Group Inc. (NASDAQ: CME) today announced it priced an underwritten public offering of $750 million aggregate principal amount of 3.00% notes due Sept. 15, 2022. The offering is being made under CME Group's existing shelf registration statement and is expected to close on Sept. 10, 2012, subject to customary closing conditions.
CME Group intends to use the net proceeds from the offering, together with cash on hand, to retire at maturity its outstanding 5.40% notes due August 2013. Although CME Group does not currently anticipate doing so, it may use some or all of the net proceeds from the offering for other, general corporate purposes.
This announcement is neither an offer to sell nor a solicitation of an offer to buy any securities and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful. Any offers of the notes will be made exclusively by means of a prospectus and prospectus supplement.
Bookrunners for the transaction include Barclays Capital Inc., Merrill Lynch, Pierce, Fenner & Smith Incorporated, UBS Securities LLC, BMO Capital Markets Corp., Citigroup Global Markets Inc., Lloyds Securities Inc., Mitsubishi UFJ Securities (USA), Inc. and Wells Fargo Securities, LLC.
Barclays Capital Inc., Merrill Lynch, Pierce, Fenner & Smith Incorporated and UBS Securities LLC are acting as representatives of the underwriters. Copies of the prospectus supplement and accompanying prospectus relating to the offering may be obtained by contacting Barclays Capital Inc. at 1-888-603-5847, Merrill Lynch, Pierce, Fenner & Smith Incorporated at 1-800-294-1322 or UBS Securities LLC at 1-877-827-6444, ext. 561-3884.